Food News and Research

RSS

FDA approves jaw joint prosthetic developed by University of Pennsylvania

After a 10-year clinical trial of a jaw joint replacement developed by Peter Quinn of the University of Pennsylvania School of Dental Medicine, the Food and Drug Administration has given it a thumbs-up.

10 Jan 2006

Study finds short-term lifestyle changes improve health even without major weight loss

Obese and overweight individuals suffering metabolic syndrome and Type 2 diabetes showed significant health improvements after only three weeks of diet and moderate exercise even though the participants remained overweight.

10 Jan 2006

Tomato juice keeps emphysema from developing in new animal model of degenerative disease

Feeding tomato juice to mice kept them from developing emphysema after cigarette smoke exposure that was long enough to induce emphysema in a control group, Japanese researchers report in February issue of the American Journal of Physiology-Lung Cellular and Molecular Physiology.

10 Jan 2006

Approval of first immune globulin for use beneath the skin

The U.S. Food and Drug Administration (FDA) has announced the approval of the first immune globulin product for subcutaneous injection for the prevention of serious infections in patients with Primary Immune Deficiency Diseases (PIDD).

10 Jan 2006

Fish oil shown to reduce airway inflammation caused by exercise-induced asthma

People suffering from exercise-induced asthma were able to reduce their symptoms below the threshold used to diagnose the disease by eating a diet supplemented with fish oil, according to new research findings from Indiana University reported in the January issue of the journal Chest.

10 Jan 2006

Loyola to study for first time IV medication for osteopenia and inflammatory bowel diseases

Researchers at the Osteoporosis and Metabolic Bone Disease Center and the Division of Gastroenterology at Loyola University Health System are studying a once-yearly, 15-minute infusion of an intravenous (IV) medication in patients with osteopenia (low bone mass) and inflammatory bowel diseases (IBD) that, if proven effective, may be considered the standard of treatment.

10 Jan 2006

Thalomid gives hope for blood cancer sufferers

Drug company Celgene says it has halted a pivotal-stage trial of its Thalomid drug earlier than expected after the drug was shown to dramatically limit the progress of the blood cancer multiple myeloma.

9 Jan 2006

Overweight people not interested in healthy lifestyle

According to a poll in the UK more than a quarter of obese and overweight people do not want to lose weight, and many were unable to identify their weight category.

9 Jan 2006

Dogs able to smell early cancers

According to a new study, man's best friend, the humble dog, may be useful in detecting early cancers.

9 Jan 2006

Clever ants may hold the secret to antibiotic resistance

New research has revealed that ants that tend and harvest gardens of fungus carry on their bodies a secret weapon, an antibiotic-producing bacteria, which works against the parasites that invade their crops.

9 Jan 2006

Psychotropic drug prescriptions for teenagers has skyrocketed

Psychotropic drug prescriptions for teenagers skyrocketed 250 percent between 1994 and 2001, rising particularly sharply after 1999, when the federal government allowed direct-to-consumer advertising and looser promotion of off-label use of prescription drugs

6 Jan 2006

Fruit bats a reservoir for Ebola virus

IRD researchers have succeeded in the first identification of bats as a potential natural reservoir of Ebola virus. Several epidemics of haemorrhagic fever have raged in the Republic of Congo and Gabon since 2001, hitting both humans and primates simultaneously.

6 Jan 2006

Data establishes safety profile of new GlaxoSmithKline rotavirus vaccine candidate

Data from one of the largest infant vaccine trials ever conducted, published in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children.

6 Jan 2006

Rotateq eliminates the most severe cases of rotavirus

In a study of more than 68,000 infants published in the New England Journal of Medicine, the investigational vaccine Rotateq demonstrated that it can safely prevent 98 percent of severe cases of viral diarrhea and vomiting that account for 2 million hospital visits and 500,000 pediatric deaths each year worldwide.

6 Jan 2006

Prospect of personalized medicine places new demands on the evaluation of new medicines

As we enter the era of personalized medicine, it is time to take a fresh look at how we evaluate new medicines and treatments for cancer, according to Donald Berry, Ph.D., professor and chair of the Department of Biostatistics and Applied Mathematics at The University of Texas M. D. Anderson Cancer Center.

6 Jan 2006

Surprise discovery helps tackle rabies

In an unexpected discovery, scientists at Jefferson Medical College have found that a tiny change in a rabies virus protein can turn a "safe" virus extremely deadly. The finding has enabled the researchers to refine a vaccine they previously created against rabies in wildlife, making it safer and more effective.

5 Jan 2006

UCLA examines disease-versus-disease interactions

The knowledge that one disease may prevent the onset of another is not new. For example, the discovery that cowpox vaccines can prevent smallpox dates back to 1798.

5 Jan 2006

Magnesium for stronger bones

Intake of magnesium through diet and supplements is positively associated with bone density throughout the whole body, particularly in older white adults, according to research published in the Journal of the American Geriatrics Society. Researchers say the effects are similar to that of calcium.

5 Jan 2006

Stroke risk increases when children with sickle cell disease cease transfusions

Stopping regular blood transfusions in children with sickle cell disease who are at risk for a stroke means their stroke risk likely will return, researchers have found.

30 Dec 2005

University of Michigan Medical School to study the science of obesity and metabolism

As millions of Americans prepare their New Year’s resolutions to lose weight, eat better or exercise more, the University of Michigan Medical School is launching a new center that may help explain why so many resolutions fail, while others succeed.

29 Dec 2005